The National Aspergillosis Centre is part of the Manchester Fungal Infection Group (MFIG) who have just published an important paper in the very prestigious Nature Communications journal.
Sara Gago in Paul Bowyer’s lab has characterised a mutation carried by people that researchers have found make their airways stickier, thus enabling Aspergillus spores to stick and grow. The implications for infection (ABPA) are pretty clear and the group have already discovered that this mutation is common in people with ABPA (28% of patients in this study had this mutation). This leads us straight to thinking about screening out people who are prone to infection as they carry this gene mutation. We can then pay special attention to prevent them getting ABPA. What this means for people who already have ABPA is less clear, but certainly suggests another target for treatment.
Share this post
Latest News posts
Spring COVID Booster
March 8, 2023
Accessing GP services
March 8, 2023
NAC CARES Virtual Challenge – Week 2
February 17, 2023
NAC CARES Virtual Challenge – Week 1
February 10, 2023
NAC CARES team charity run for the Fungal Infection Trust
January 31, 2023
Diagnosis
December 2, 2022
Loneliness and Aspergillosis
November 30, 2022
Doing a disability assessment
November 21, 2022
Finding an advocate
November 21, 2022
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video